慧宝源HEBABIZ品牌怎么样 申请店铺

更新时间:2024-10-28
慧宝源HEBABIZ是哪个国家的品牌?「慧宝源HEBABIZ」是 广西慧宝源健康产业有限公司 旗下著名品牌。该品牌发源于广西钦州市,由创始人詹姆 * ·周在2013年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
慧宝源HEBABIZ怎么样

广西慧宝源医药科技有限公司(以下称慧宝源)由国家”科技创新创业人才”入选者、美国耶鲁大学归国学者于2013年创建,设在钦州产业园,占地约470亩,注册资金2亿元。

企业专注于抗肿瘤和肝病药物研究开发,专注于提升中药质量标准,生产供应高品质中成药,努力推动传统中药走向世界。

慧宝源拥有目前有90个药品批文,180多项国际国内授权专利,已建成1个抗肿瘤药物研究中心、3个技术中心、1个院士工作站、1个博士后创新基地以及68000平米高品质的中成药生产基地。规划在建的化药生产基地与中成药生产基地相互呼应,中国—马来西亚钦州产业园区管理委员会和慧宝源一起打造的一个公共创新服务平台,为同是医药行业的合作伙伴提供创新药物研发、生产、销售一体化的服务。

公司产品线丰富,涵盖:肠胃、呼吸、肝胆、皮肤、心脑血管、神经、口腔、伤痛等品类;既有口服制剂系列,还有药酒系列和外用制剂系列。另外,公司还生产中药细粉、功能食品等产品。

慧宝源充分利用国际国内两大市场,在国内建立了广泛的产品销售网络,与国药控股、上药集团、华润控投、九州通等全国性主流商业,以及阿里健康、康爱多、好药师等连锁大药房,建立了良好的合作关系。在国际市场,慧宝源与马来西亚较大医药进出口商海鸥集团达成了战略合作。


Guangxi huibaoyuan Pharmaceutical Technology Co., Ltd. (hereinafter referred to as huibaoyuan) was founded in 2013 by the national "science and technology innovation and entrepreneurship talents" selected and returned scholars from Yale University in the United States. It is located in Qinzhou Industrial Park, covering an area of about 470 mu, with a registered capital of 200 million yuan. The company focuses on the research and development of anti-tumor and hepatopathy drugs, focuses on improving the quality standards of traditional Chinese medicine, produces and supplies high-quality Chinese patent medicine, and strives to promote the traditional Chinese medicine to the world. At present, huibaoyuan has 90 drug approvals and more than 180 international and domestic authorized patents. It has built an anti-tumor drug research center, three technology centers, an academician workstation, a postdoctoral innovation base and a 68000 square meter high-quality Chinese patent production base. The planned chemical medicine production base and Chinese patent medicine production base echo each other. The Management Committee of China Malaysia Qinzhou Industrial Park and huibaoyuan jointly build a public innovation service platform to provide innovative medicine research and development, production and sales integration services for partners in the pharmaceutical industry. The company's product line is rich, covering: gastrointestinal, respiratory, hepatobiliary, skin, cardio cerebrovascular, nerve, oral, pain and other categories; there are not only oral preparation series, but also liquor series and external preparation series. In addition, the company also produces fine powder of traditional Chinese medicine, functional food and other products. Huibaoyuan has made full use of the two major international and domestic markets, established a wide range of product sales network in China, and established a good cooperative relationship with national mainstream businesses such as Sinopharm holdings, Shanghai Pharmaceutical Group, China Resources holding investment, Jiuzhoutong, as well as chain drugstores such as Ali health, kangaido, and haoyaoshi. In the international market, huibaoyuan has reached strategic cooperation with Haiou group, a large pharmaceutical importer and exporter in Malaysia.

本文链接: https://brand.waitui.com/1a6c5e9a3.html 联系电话:0777-2223618

千城特选小程序码

7×24h 快讯

晋控煤业:前三季度归母净利润21.51亿元,同比降0.62%

36氪获悉,晋控煤业发布第三季度财报。财报显示,前三季度实现营业收入112.34亿元,同比下降0.19%;归属于上市公司股东的净利润21.51亿元,同比下降0.62%。第三季度实现营业收入38.55亿元,同比增长1.38%;归属于上市公司股东的净利润7.14亿元,同比下降8.25%。

19分钟前

财政部:1-9月国有企业营业总收入同比增长1.2%,利润总额同比下降2.3%

36氪获悉,财政部发布数据,1-9月,全国国有及国有控股企业营业总收入同比增长1.2%,利润总额同比下降2.3%。1-9月,国有企业营业总收入610580.1亿元,同比增长1.2%。1-9月,国有企业利润总额32487.0亿元,同比下降2.3%。1-9月,国有企业应交税费44136.7亿元,同比增长0.1%。9月末,国有企业资产负债率64.9%,上升0.1个百分点。

19分钟前

立昂微:第三季度营收8.18亿元,同比增长21.94%

36氪获悉,立昂微发布第三季度财报。财报显示,第三季度营收为8.18亿元,同比增长21.94%;净利润为1251.44万元,同比增长6.63%。

19分钟前

万兴科技万兴喵影焕新升级,推出十余项AI功能

36氪获悉,近日,万兴科技旗下视频创意软件万兴喵影桌面端发布全新版本万兴喵影2025。据了解,万兴喵影2025一次性新增上线超十项AI功能,助力视频创作增效提质,如AI翻译唇形驱动、智能马赛克等创作增效功能,以及AI超清、AI人声美化等视频提质功能。

19分钟前

立邦涂料宣布23亿美元收购复合材料供应商AOC

日本立邦涂料公司周一宣布,计划以23亿美元收购全球化学品配方制造商LSF11 A5 TopCo LLC,后者是是涂料、着色剂和复合树脂生产商AOC的母公司。根据周一提交给交易所的文件,这家日本涂料和化学品制造商表示,其目标是在2025财年上半年完成这笔交易,并将立邦涂料表示,此交易对当前日历年的任何财务影响都应该是微不足道的。(新浪财经)

19分钟前

本页详细列出关于慧宝源HEBABIZ的品牌信息,含品牌所属公司介绍,慧宝源HEBABIZ所处行业的品牌地位及优势。
咨询